Background: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is used to temporarily control bleeding and maintain the cerebral and coronary blood flow in cases in which it is difficult to control hemorrhagic shock. However, the safety and effectiveness of REBOA remains uncertain.
Objectives: This study aimed to estimate the safety and effectiveness of aortic occlusion in patients who undergo REBOA catheter placement.
Methods: We conducted a retrospective study of patients who underwent REBOA catheter placement at Fukuyama City Hospital Emergency Medical Center from August 1, 2008 to March 31, 2020. A propensity score-matching analysis was used to compare 30-day survival between patients who undergo REBOA catheter placement with and without aortic occlusion.
Results: Overall, 122 of the 147 who underwent REBOA catheter placement at Fukuyama City Hospital were eligible for inclusion. Thirty-five patients in the Occlusion group and 35 patients in the Nonocclusion group were selected by propensity score matching. According to the 30-day survival rate, the difference between the two groups was not statistically significant (p = 0.288 log-rank test). Moreover, the required treatment, the types and incidence of complications, and other outcomes did not differ according to the presence or absence of aortic occlusion in patients who underwent REBOA catheter placement.
Conclusion: According to the results of this study, in trauma patients who undergo REBOA catheter placement, the presence of aortic occlusion was not significantly associated with 30-day mortality. Furthermore, the performance of aortic occlusion was not associated with a significant increase in complications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jemermed.2021.11.017 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
PARTIAL OCCLUSION, LESS AKI: AN AORTA REGISTRY ANALYSIS OF PREBOA-PRO.
Shock
January 2025
Denver Health, Denver, Colorado.
Background: Noncompressible torso hemorrhage remains a leading cause of potentially preventable deaths. Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) has emerged as an adjunct temporizing hemorrhage control. The complete occlusion strategy with the ER-REBOA catheter can cause distal ischemia when used for longer than 30 min.
View Article and Find Full Text PDFCompact Arterial Monitoring Device Use in Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA): A Simple Validation Study in Swine.
Cureus
October 2024
Department of Anesthesiology, Uniformed Services University of the Health Sciences, Bethesda, USA.
Article Synopsis
- - Hemorrhage is the main cause of preventable death in trauma situations, leading to military and civilian advancements in medical practices, particularly through the use of tourniquets to manage extremity bleeding and save lives.
- - While tourniquets have significantly decreased deaths from bleeding in military settings, noncompressible hemorrhage still poses a major risk, especially before patients receive definitive medical care.
- - The study explores using a small, disposable pressure monitor during resuscitative endovascular balloon occlusion of the aorta (REBOA) to enhance blood pressure monitoring, facilitate better resuscitation practices, and reduce the need for blood products in extreme environments.
Cerebral haemodynamics and intracranial pressure during haemorrhagic shock and resuscitation with total endovascular balloon occlusion of the aorta in an animal model.
Eur J Trauma Emerg Surg
December 2024
Department of Neurosurgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
Article Synopsis
- The study aimed to examine how total REBOA (tREBOA) affects cerebral blood flow and intracranial pressure (ICP) in pigs during controlled hemorrhagic shock and subsequent resuscitation.
- Researchers used 22 anesthetized pigs, splitting them into two groups: one with elevated ICP (EICPG) and one with normal ICP (NICPG), and monitored their vital parameters before and after inducing shock.
- Results showed that tREBOA effectively restored cerebral perfusion in both groups, even with periods of impaired autoregulation, confirming its potential as a lifesaving intervention during critical resuscitation scenarios.
Successful Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) deployment by emergency medicine physicians for refractory non-traumatic cardiac arrest.
Resusc Plus
December 2024
Department of Emergency Medicine, University of Utah, Salt Lake City, UT, USA.
Article Synopsis
- Cardiac arrest affects over 600,000 people each year in the U.S., and survival rates have not improved. REBOA, typically used for severe trauma cases, is being explored for use in refractory non-traumatic cardiac arrest to improve blood flow to the heart and brain.
- The study outlined a training program for emergency medicine physicians to perform REBOA in the emergency department, detailing the training and clinical outcomes from their first eight cases, all of which were successfully catheterized on the first attempt.
- While REBOA placement showed a 37.5% rate of return of spontaneous circulation (ROSC) among patients, none survived to hospital discharge, indicating the need for further
Resuscitative endovascular balloon occlusion of the aorta (REBOA) for non-trauma patients in an urban hospital: a series of two cases.
Trauma Surg Acute Care Open
September 2024
Trauma Research Unit, Department of Trauma Surgery, Erasmus Medical Center, Rotterdam, The Netherlands.
Background: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is increasingly being used for temporary bleeding control in patients with trauma with non-compressible truncal hemorrhage (NCTH). In recent years, the technique is gaining popularity in postpartum hemorrhage and non-traumatic cardiac arrest, although still underutilized. In other surgical fields, however, there is not yet much awareness for the possible advantages of this technique.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!